Covalon Technologies Ltd CVALF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.80
- Day Range
- $0.77–0.84
- 52-Week Range
- $0.73–1.58
- Bid/Ask
- $0.53 / $1.38
- Market Cap
- $18.87 Mil
- Volume/Avg
- 11,500 / 9,066
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.02
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 4.03%
Company Profile
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- —
- Website
- https://www.covalon.com
Valuation
|
Metric
|
CVALF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.42 |
Price/Sales | 1.02 |
Price/Cash Flow | — |
Price/Earnings
CVALF
Financial Strength
|
Metric
|
CVALF
|
|---|---|
Quick Ratio | 3.10 |
Current Ratio | 4.81 |
Interest Coverage | — |
Quick Ratio
CVALF
Profitability
|
Metric
|
CVALF
|
|---|---|
Return on Assets (Normalized) | −16.77% |
Return on Equity (Normalized) | −21.38% |
Return on Invested Capital (Normalized) | −20.21% |
Return on Assets
CVALF
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Dlkjqtkjv | Kwfcj | $562.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Pzlsnjhr | Xwcqcq | $103.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Rtrqtzc | Hklrcjf | $99.5 Bil | |
MRNA
| Moderna Inc | Jphvhsky | Dbk | $38.8 Bil | |
ARGX
| argenx SE ADR | Wlwmmsqc | Gcb | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Mktmgkkc | Wfs | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Wxhsyztbw | Nzkdtgn | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Bsrynnxh | Cnnnzb | $17.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Scqdldqmn | Ngxqrl | $12.5 Bil | |
INCY
| Incyte Corp | Dbjljtbq | Vfkjd | $11.6 Bil |